Single-dose pharmacokinetic study of ciprofloxacin and fleroxacin in healthy adult Nigerian volunteers

Chemotherapy

Volumn 44, Issue 6, 1998, Pages 369-376

  Chukwuani, C M ^a,b   Coker, H A B ^a   Oduola, A M J ^b   Ifudu, N D ^a   Sowunmi, A ^b  

^a UNIVERSITY OF LAGOS   (Nigeria)

^b NONE

Author keywords

Ciprofloxacin; Fleroxacin; Nigerians; Pharmacokinetics

Indexed keywords

ANTIBIOTIC AGENT; CIPROFLOXACIN; FLEROXACIN;

ARTICLE; CLINICAL TRIAL; COMPUTER PROGRAM; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG URINE LEVEL; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; MATHEMATICAL MODEL; MICROCOMPUTER; NEGRO; NIGERIA; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS;

ABSORPTION; ADULT; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLEROXACIN; HUMANS; INFUSIONS, INTRAVENOUS; MALE; TISSUE DISTRIBUTION;

EID: 0031694947     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007146     Document Type: Article

References (21)

1. Bergan T, Thorteinsson S: Pharmacokinetics and bioavailability study of Ciprofloxacin. Proceedings of the 1st International Ciprofloxacin Workshop, Leverkusen, 1985. Excerpta Med Curr Clin Pract Ser 1986;34:111.
2. Forest A, Drusano GL, Plaisance K, Knoll G, Gonzalez MA: Multiple-dose pharmacokinetics of ciprofloxacin and two of its metabolites as determined in normal volunteers. Excerpta Med Curr Clin Pract Ser 1986;34:122.
3. Wingender W, Beermann D, Forster D, Graefa KH, Kuhlman J: Interactions of ciprofloxacin with food intake and drugs. Excerpta Med Curr Clin Pract Ser 1986;34:136.
4. Nightingale CH: Overview of the pharmacokinetics of fleroxacin. Am J Med 1993;94(suppl 3A):385-435.
5. Malter U, Jaehde U, Sorgel F, Stephen U, Hoffler D: Individual factors affecting the pharmacokinetics of pefloxacin (abstract No. 17). Proceedings of the 15th International Congress of Chemotherapy, 1987.
6. Plaisance KK, Drusano GL, Forest A, Bustamante CI, Standiford HC: Effect of dose size on bioavailability of ciprofloxacin. Antimicrob Agents Chemother 1987;31:956-958.
7. Vessel ES, Page JG: Genetic control of drug levels in man: Anti-pyrine. Science 1966;161:72-74.
8. Heizmann F, Dell D, Eggers H, Gora R: Determination of the new fluoroquinolone fleroxacin and its N-demethyl and N-oxide metabolites in plasma and urine by HPLC with fluorescence detection. J Chromatogr 1990;327:91-101.
9. Weidekamm E, Portman R, Pantos C, Dell D: Single and Multiple dose Pharmacokinetics of Fleroxacin. J Antimicrob Chemother 1988; 22(suppl D):145-154.
10. Cullmann W, Geddes AM, Weidekamm E, Urwyler H, Braunsteriner A: Fleroxacin: A review of its chemistry, microbiology, toxicology, pharmacokinetics clinical efficacy and safety. Int J Antimicrob Agents 1993;1:203-230.
11. Lode H, Hampel B, Wachter T, Borner K, Koeppe P, Weidekamm E: Comparative pharmacokinetic investigation; fleroxacin versus ciprofloxacin versus ofloxacin following oral administration. Research Report No. B-116 019, Sept 13, 1988.
12. Vance-Bryan K, Guay DR, Rotschafer JC: Clinical pharmacokinetics of ciprofloxacin. Clin Pharmacokinct 1990;19:434-461.
13. Sorgel F, Kinzig M: Pharmacokinetics of gyrase inhibitors. I. Basic chemistry and gastrointestinal disposition. Clin Pharmacokinet 1990; 19:445-555.
14. Le Bel M: Pharmacokinetics of Oral Fluoroquinolones. ISI Atlas of Science: Pharmacology 1988, pp 196-201.
15. Gibaldi M, Levy G, McNamara PJ: Effect of plasma protein and tissue binding on the biologic half-life of drugs. Clin Pharmacol Ther 1978; 24:1-4.
16. Wilkinson GR, Shand DG: A physiologic approach to hepatic drug clearance. Clin Pharmacol Ther 1975;18:377.
17. Webb DB, Roberts DE, Williams JD, Asscher AW: Pharmacokinetics of ciprofloxacin in healthy volunteers and inpatients with impaired renal function. J Antimicrob Chemother 1986;18(suppl D):83-87.
18. Drusano GL, Standford HC, Plaisance K, Forrest A, Leslie J, Caldwell J: Absolute oral bioavailability of ciprofloxacin. Antimicrob Agents Chemother 1986;30:444-446.
19. Hoffken G, Lode H, Prinzing C, Borner K, Koeppe P: Pharmacokinetics of ciprofloxacin after oral and parenteral administration. Antimicrob Agents Chemother 1985;27: 375-379.
20. Borner K, Hoffken G, Lode H, Koeppe P, Prinzing C, Glatzel P, Wiley R, Olschewski P, Sievers B, Reinitz D: Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administration. Eur J Clin Microbiol 1986;5: 179-186.
21. Drusano GL, Plaisance KI, Forrest A, Standford AL: Dose ranging study and constant infusion evaluation of ciprofloxacin. Antimicrob Agents Chemother 1988;30:440-443.